In contrast to the above studies, reports on breast cancer, nasopharyngeal carcinoma and pleomorphic gliomas revealed that EFEMP1 was decreased, and inhibited tumor invasion and metastasis [12–14]. Here, EFEMP1 is linked to nasopharyngeal carcinoma.